| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.70▲ | 3.70▲ | 3.71▲ | 3.73▼ | 3.78▼ |
| MA10 | 3.71▲ | 3.72▼ | 3.73▼ | 3.74▼ | 4.12▼ |
| MA20 | 3.70▲ | 3.73▼ | 3.72▼ | 3.85▼ | 4.69▼ |
| MA50 | 3.71▲ | 3.75▼ | 3.72▼ | 4.19▼ | 5.28▼ |
| MA100 | 3.74▼ | 3.74▼ | 3.82▼ | 4.79▼ | 5.70▼ |
| MA200 | 3.74▼ | 3.84▼ | 3.78▼ | 5.20▼ | 3.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.001▼ | 0.021▲ | -0.090▼ |
| RSI | 52.848▲ | 47.910▼ | 47.805▼ | 43.325▼ | 37.770▼ |
| STOCH | 38.889 | 36.520 | 32.308 | 31.964 | 20.507 |
| WILL %R | -41.667 | -58.065 | -67.347 | -70.423 | -79.960▼ |
| CCI | 29.615 | -57.329 | -25.667 | -74.059 | -84.300 |
|
Sunday, June 08, 2025 05:00 PM
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...
|
|
Friday, June 06, 2025 08:45 AM
US cardiorenal-focussed drugmaker Ardelyx (Nasdaq: ARDX) announced that Mike Kelliher, formerly executive vice president, corporate development and strategy, has been promoted to chief business ...
|
|
Monday, May 26, 2025 05:38 PM
In this article, we are going to take a look at where Ardelyx, Inc. (NASDAQ:ARDX) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.665 | 3.74 | 3.65 | 3.715 | 1,375,376 |
| 12/06/25 | 3.74 | 3.88 | 3.70 | 3.72 | 6,866,757 |
| 11/06/25 | 3.76 | 3.79 | 3.63 | 3.70 | 5,649,995 |
| 10/06/25 | 3.78 | 3.88 | 3.73 | 3.735 | 4,857,435 |
| 09/06/25 | 3.73 | 3.77 | 3.61 | 3.76 | 5,289,925 |
| 06/06/25 | 3.68 | 3.805 | 3.67 | 3.68 | 6,929,427 |
| 05/06/25 | 3.70 | 3.76 | 3.62 | 3.64 | 3,137,090 |
| 04/06/25 | 3.95 | 3.955 | 3.625 | 3.69 | 7,197,137 |
| 03/06/25 | 3.85 | 3.97 | 3.75 | 3.93 | 3,918,967 |
| 02/06/25 | 3.71 | 3.93 | 3.5701 | 3.85 | 5,238,457 |
|
|
||||
|
|
||||
|
|